Clinical Trial Update: A Study of SI-6603 in Patients With Lumbar Disc Herniation [Phase 3]

View source ↗

Summary

Phase 3 trial update for SI-6603 in patients with lumbar disc herniation/intervertebral disc disease completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intervertebral Disc Disease
• Lumbar Disc Disease

Drugs mentioned

• SI-6603

Snippet

Sponsor: Seikagaku Corporation | Conditions: Intervertebral Disc Disease, Lumbar Disc Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-11-11